QA: Chemours Co in us_medicinal_products/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001627223_2019_Chemours_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001627223, Chemours Co

  xvar xval
0 LiabilitiesNoncurrent 4,416,000,000
1 LiabilitiesCurrent 1,709,000,000
2 remainder_Liabilities 217,000,000
3 AssetsCurrent 3,293,000,000
4 AssetsNoncurrent 597,000,000
5 PropertyPlantAndEquipmentNet 3,291,000,000
6 Goodwill 0
7 remainder_Assets 181,000,000
8 GeneralAndAdministrativeExpense 5,324,000,000
9 ResearchAndDevelopmentExpense 82,000,000
10 remainder_Expenses 403,000,000
11 remainder_Revenues 6,638,000,000
12 remainder_NetIncome 167,000,000
13 remainder_ComprehensiveNetIncome -123,000,000
  yvar yval
0 Liabilities 6,342,000,000
1 Assets 7,362,000,000
2 Expenses 5,809,000,000
3 Revenues 6,638,000,000
4 StockholdersEquity 1,020,000,000
5 NetIncome 996,000,000
6 ComprehensiveNetIncome 934,500,000
7 BaseVar 13,220,500,000
8 EconomicCapitalRatio 0.263

Edgar->Model Mapping

Feature Distribution

Change over Time